Advisor Group Holdings, Inc. Atai Life Sciences N.V. Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,452 shares of ATAI stock, worth $6,869. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,452
Previous 3,632
4.96%
Holding current value
$6,869
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ATAI
# of Institutions
104Shares Held
16.3MCall Options Held
367KPut Options Held
69.2K-
Morgan Stanley New York, NY3.33MShares$6.63 Million0.0% of portfolio
-
Ubs Group Ag1.94MShares$3.86 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$2.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny982KShares$1.95 Million0.0% of portfolio
-
Davidson Kempner Capital Management LP New York, NY949KShares$1.89 Million0.03% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $330M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...